Advertisements

therapeutics

Diabetes drugmaker Structure Therapeutics stock soars 72% in market debut

by

[ad_1] ismagilov/iStock via Getty Images Structure Therapeutics (GPCR) stock rallied 72% in afternoon trading Friday after the diabetes drug developer raised $161M through an upsized US initial public offering. American Depositary Shares of the company, which has operations in both the US and China, opened at $25 after being priced at $15 apiece. The stock … Read more

Tenax Therapeutics stock dips after pricing $15.6M securities offering (NASDAQ:TENX)

by

[ad_1] Tenax Therapeutics (NASDAQ:TENX) shares fell 14% after the pharmaceutical company priced its $15.6M securities offering. The offering comrpises 8.66M shares of common stock (or pre-funded warrants in lieu thereof) and (ii) warrants to purchase up to 17.33M shares, issued at a purchase price of $1.80 per share and associated public warrant. The warrants will … Read more